
Last updated: 2026-09-16 10:31:40. Prices reflect the latest pre-market trading data. Stock price data is sourced from Massive.
Teleflex Incorporated (TFX) operates in the SURGICAL & MEDICAL INSTRUMENTS & APPARATUS sector and is listed on NYSE. The stock is currently priced at $129.45, with a market capitalisation of $5.52B and a P/E ratio of --. Over the past 52 weeks, its price has ranged from $100.18 to $145.00. This page covers its latest market performance, valuation, price trends and company information.
$5.52B | |
$128.85 | |
$449.38 | |
$37.21 | |
$129.02 | |
2.65K | |
544.22K | |
-- | |
$145.00 | |
$100.18 | |
1.10% | |
-- |
Teleflex Incorporated (TFX) is trading at $129.45 in pre-market trading as of 2026-09-16 08:46:53, up 0.33% ($0.43) from the previous close of $129.02
Pre-market trading shows how investors are pricing TFX before the regular session opens. The current pre-market price is near the previous close, indicating positive early trading sentiment.
Over the past seven days, Teleflex Incorporated (TFX) moved from $138.36 to $129.45, representing a decline of 6.44% ($8.91).
The stock traded between $126.18 and $140.59 during the period. The latest price is near the lower end of the 7-day range, indicating strong downward.
The average daily volume was 652.04 thousand shares, up versus the previous seven-day period, indicating higher trading activity.
Position in Range: 65.3%
TFX is currently trading at $129.45, placing it 65.3% of the way from its 52-week low of $100.18 to its 52-week high of $145.00. This percentage reflects the stock's relative position within its 52-week trading range, not its valuation or future performance.
Teleflex Inc is a provider of medical technology products focused on enhancing clinical benefits, improving patient and provider safety and reducing total procedural costs. It designs, develops, manufactures and supply medical devices used by hospitals and healthcare providers supporting high-acuity emergent procedures. The company has three reportable segments: Americas, EMEA (Europe, the Middle East and Africa) and Asia (Asia Pacific). It derives maximum revenue from Americas. Its products includes: Anaesthesia, Emergency Medicine, Interventional Cardiology/Radiology, Interventional Urology - UroLift System, Surgery, Urology, and Vascular Access.
| Industry | SURGICAL & MEDICAL INSTRUMENTS & APPARATUS |
| Employees | 15500 |
| Exchange | NYSE |
| Company Website |
Eligible investors can buy real shares of Teleflex Incorporated (TFX) through MEXC RealStocks. Follow these three steps to open a RealStocks account, transfer USDT, and place a US stock order.